Jeffrey R. Aeschlimann
Associate Professor/Pharmacy Practice

Are you Jeffrey R. Aeschlimann?

How to update your information.
Treatment of UTIs due to ESBL Pathogens: Considerations for the Emergency Department
2024
Jeffrey R Aeschlimann
Research Type: Poster/Presentation

Extended infusion dosing of beta-lactam antibiotics in critically ill patients
2024
David Banach, Jeffrey R Aeschlimann, Gillian Kuszewski
Research Type: Poster/Presentation

Immunization: It is now time to make it unclear - Reconciling differences between Public Health recommendations and FDA Product Labeling for Vaccines
2023
Jeffrey R Aeschlimann
Research Type: Poster/Presentation

Beta Get it Right! Impact of Multidisciplinary Education of Allergy Documentation and Beta-Lactam Deprescribing
2023
Marrium Quereshi, Gabriella Salerno, Jeffrey R Aeschlimann, Gillian Kuszewski, Cassandra Doyno
Research Type: Poster/Presentation

Management of UTIs due to ESBL Pathogens: Options for Therapy across the Care Continuum
2023
Jeffrey R Aeschlimann
Research Type: Poster/Presentation

Optimization of the emergency department culture review process through enhancement of the electronic medical record
2022
Kevin Chamberlin, Marissa Salvo, Gillian Kuszewski, Cassandra Doyno, Stephen Bordonaro, Daniel Vo, Jeffrey R Aeschlimann, Nishi Patel, Megan Pantos, Youssef Bessada
Research Type: Poster/Presentation

Use of Epic Smart-set and Faculty Education to Improve Antibiotic Stewardship for Patients with Urinary Symptoms Presenting to the Emergency Department: A Quality Improvement Study.
2022
Gillian Kuszewski, Matthew Babcock, Lemuel Hackshaw, Cassandra Doyno, Jeffrey R Aeschlimann, David Banach
Research Type: Poster/Presentation

Beta get it right! Impact of multidisciplinary education on allergy documentation and beta-lactam deprescribing.
2022
Jeffrey R Aeschlimann, Gabriella Salerno, Marriam Quereshi, Cassandra Doyno, Gillian Kuszewski
Research Type: Poster/Presentation

Immunization: Is Winter Here? – An Update on Monkey Pox and Covid Vaccines
2022
Jeffrey R Aeschlimann
Research Type: Poster/Presentation

Update on Newer Antibacterials (and New Uses for “Older” Antibacterials)
2022
Jeffrey R Aeschlimann
Research Type: Poster/Presentation

“Ivermectin is a Nobel Prize winning wonder drug – but not for COVID-19"
2021
Jeffrey R Aeschlimann
Research Type: Other Scholarly Work

ABSTRACT 30: Evaluation of Procalcitonin Use in Patients Discharged from the Emergency Department with Acute Respiratory Infection.
2021
Garrett Fontaine, Jeffrey R Aeschlimann, David Banach
Research Type: Poster/Presentation

Implementation of a Pharmacist-Driven Antibiotic Time out and Its Effect on Antibiotic Prescribing in Patients Admitted with Suspected Community Acquired Pneumonia or Urinary Tract Infection.
2021
Jeffrey R Aeschlimann, Leah Leszcynski, Marrium Quereshi, Kaitlyn Elliott, Gillian Kuszewski
Research Type: Poster/Presentation

Optimization of the Emergency Department Culture Review Process through Enhancement of the Electronic Medical Record
2021
Cassandra Doyno, Marissa Salvo, Nishi Patel, Kevin Chamberlin, Daniel Vo, Youssef Bessada, Jeffrey R Aeschlimann, Stephen Bordonaro, Gillian Kuszewski, Megan Pantos
Research Type: Poster/Presentation

Immunization: “These go to 11” – Vaccine Boosters for the Amplification of Immunity
2021
Jeffrey R Aeschlimann
Research Type: Poster/Presentation

Vancomycin therapeutic target attainment for patients with obesity: Impact of a collaborative practice vancomycin dosing protocol.
2021
Jeffrey R Aeschlimann, Emma Rehberg, Nicholas McInnis
Research Type: Poster/Presentation

Evaluation of the Effects of a Transition to AUC-Based Vancomycin Collaborative Practice Pharmacy Dosing and Monitoring on Pharmacist Workload and Stewardship Outcomes.
2021
Jeffrey R Aeschlimann, Lindsey Taupier
Research Type: Poster/Presentation

Mind your Pee’s & Q’s: Antimicrobial Stewardship Activities to Improve Urinary Tract Infection Management
2021
Jeffrey R Aeschlimann
Research Type: Poster/Presentation

Potential Clinical Benefits of Using Novel Oral Beta-lactam Combination Therapy for Step-Down Treatment of Urinary Tract Infections Caused by Extended-Spectrum Beta Lactamase (ESBL)-Producing Bacteria.
2021
Jeffrey R Aeschlimann, Alexander Connery
Research Type: Poster/Presentation

Influence of ambiguous presentation of procalcitonin results on clinician decision-making in regard to antibiotic therapy.
2021
Jeffrey R Aeschlimann, Hooman Kashi
Research Type: Poster/Presentation